Chronic non-cancer pain management illustrates the case for reconceptualising chronic condition management using a generic lifestyle-based approach.

Australian primary healthcare has been transitioning from episodic to continuous care of patients with diabetes.

Diabetes is the fastest growing chronic disease in Australia, with 1.2 million people known to have type 1, type 2 or gestational diabetes.

An update on the various treatment methods available today to tackle pilonidal disease.

Health coaching is an integral part of lifestyle medicine that can be used to facilitate behaviour change in key lifestyle areas.

Promoting insulin as a normal part of the diabetes continuum and a beneficial change for long-term health will further improve patients’ experience during the commencement of insulin.

Despite the availability of effective therapies and a national medicines subsidy scheme, a significant burden of disease still exists in Australia, with high mortality by international standards.

Nocturia is associated with significant morbidity and is likely to be a marker of poor health.

This study shows the importance of sharing and learning from policy differences.

Street-based general practice services are critical to facilitate easy access to primary and secondary management of chronic multimorbid conditions in marginalised patients.

General practitioners are well positioned to take a comprehensive approach to the management of functional decline in older people, aided by a range of funded programs.

Involving patients in the clinical decision-making process is integral to providing individualised care and is promoted as a hallmark of good clinical practice.

Diagnosis of PCOS in an Aboriginal primary care setting is being performed correctly and at a young age; however, subsequent screening of cardiometabolic risk and emotional wellbeing needs more work.

The detection of primary aldosteronism in hypertensive patients is delayed and associated with end-organ injury potentially preventable with a timely diagnosis with targeted treatment.

The study confirms under-treatment of Australian adults at high cardiovascular disease risk and indicates potential for health gains with increased implementation of evidence-based guidelines.